Estimation of Direct Healthcare Costs of Fungal Diseases in the United States | Zendy

Kaitlin Benedict | Zendy; Brendan R. Jackson | Zendy; Tom Chiller | Zendy; Karlyn D. Beer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Estimation of Direct Healthcare Costs of Fungal Diseases in the United States

Author(s) -

Kaitlin Benedict,

Brendan R. Jackson,

Tom Chiller,

Karlyn D. Beer

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy776

Subject(s) - medicine , health care , ambulatory care , total cost , emergency medicine , ambulatory , indirect costs , public health , cost estimate , environmental health , medical emergency , family medicine , surgery , management , economics , economic growth , business , accounting , nursing , microeconomics

Fungal diseases range from relatively-minor superficial and mucosal infections to severe, life-threatening systemic infections. Delayed diagnosis and treatment can lead to poor patient outcomes and high medical costs. The overall burden of fungal diseases in the United States is challenging to quantify, because they are likely substantially underdiagnosed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research